Ajanta Pharma Limited (AJANTPHARM.NS)
INR 2876.45
(-0.56%)
INR 2876.45
(-0.56%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 64.82 INR | 41.25% |
| 2022 | 45.89 INR | -16.52% |
| 2021 | 54.97 INR | 9.81% |
| 2020 | 50.06 INR | 40.11% |
| 2019 | 35.73 INR | 21.86% |
| 2018 | 29.32 INR | -17.41% |
| 2017 | 35.50 INR | -7.53% |
| 2016 | 38.39 INR | 21.91% |
| 2015 | 31.49 INR | 34.06% |
| 2014 | 23.49 INR | 32.34% |
| 2013 | 17.75 INR | 108.58% |
| 2012 | 8.51 INR | 45.22% |
| 2011 | 5.86 INR | 52.21% |
| 2010 | 3.85 INR | 49.22% |
| 2009 | 2.58 INR | 33.68% |
| 2008 | 1.93 INR | 16.27% |
| 2007 | 1.66 INR | 49.55% |
| 2006 | 1.11 INR | 18.09% |
| 2005 | 0.94 INR | 25.33% |
| 2004 | 0.75 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 17.27 INR | -11.62% |
| 2024 Q1 | 19.54 INR | 21.37% |
| 2023 Q1 | 16.53 INR | 70.24% |
| 2023 Q2 | 15.51 INR | -6.17% |
| 2023 FY | - INR | 41.25% |
| 2023 Q3 | 16.68 INR | 7.54% |
| 2023 Q4 | 16.10 INR | -3.48% |
| 2022 Q1 | 13.63 INR | 16.5% |
| 2022 FY | - INR | -16.52% |
| 2022 Q4 | 9.71 INR | -7.52% |
| 2022 Q2 | 12.22 INR | -10.34% |
| 2022 Q3 | 10.50 INR | -14.08% |
| 2021 Q2 | 15.10 INR | 12.77% |
| 2021 FY | - INR | 9.81% |
| 2021 Q1 | 13.39 INR | 9.13% |
| 2021 Q4 | 11.70 INR | -20.84% |
| 2021 Q3 | 14.78 INR | -2.12% |
| 2020 FY | - INR | 40.11% |
| 2020 Q2 | 13.01 INR | 15.23% |
| 2020 Q3 | 13.61 INR | 4.61% |
| 2020 Q1 | 11.29 INR | 14.39% |
| 2020 Q4 | 12.27 INR | -9.85% |
| 2019 Q4 | 9.87 INR | 20.07% |
| 2019 Q1 | 8.76 INR | 29.01% |
| 2019 FY | - INR | 21.86% |
| 2019 Q2 | 8.89 INR | 1.48% |
| 2019 Q3 | 8.22 INR | -7.54% |
| 2018 Q2 | 9.50 INR | 18.6% |
| 2018 Q1 | 8.01 INR | 11.87% |
| 2018 FY | - INR | -17.41% |
| 2018 Q4 | 6.79 INR | 33.93% |
| 2018 Q3 | 5.07 INR | -46.63% |
| 2017 Q3 | 11.17 INR | 11.81% |
| 2017 Q2 | 9.99 INR | 39.14% |
| 2017 FY | - INR | -7.53% |
| 2017 Q1 | 7.18 INR | -16.9% |
| 2017 Q4 | 7.16 INR | -35.9% |
| 2016 Q3 | 10.79 INR | 8.99% |
| 2016 Q4 | 8.64 INR | -19.93% |
| 2016 FY | - INR | 21.91% |
| 2016 Q2 | 9.90 INR | 9.39% |
| 2016 Q1 | 9.05 INR | 9.7% |
| 2015 FY | - INR | 34.06% |
| 2015 Q4 | 8.25 INR | -4.4% |
| 2015 Q3 | 8.63 INR | 10.08% |
| 2015 Q2 | 7.84 INR | 20.25% |
| 2015 Q1 | 6.52 INR | 14.99% |
| 2014 Q4 | 5.67 INR | -19.57% |
| 2014 Q3 | 7.05 INR | 12.08% |
| 2014 Q1 | 4.53 INR | 0.0% |
| 2014 FY | - INR | 32.34% |
| 2014 Q2 | 6.29 INR | 38.85% |
| 2013 FY | - INR | 108.58% |
| 2012 Q4 | 4.33 INR | 16.71% |
| 2012 FY | - INR | 45.22% |
| 2012 Q1 | 2.23 INR | 0.0% |
| 2012 Q2 | 2.49 INR | 11.66% |
| 2012 Q3 | 3.71 INR | 49.0% |
| 2011 FY | - INR | 52.21% |
| 2010 FY | - INR | 49.22% |
| 2009 FY | - INR | 33.68% |
| 2008 FY | - INR | 16.27% |
| 2007 FY | - INR | 49.55% |
| 2006 FY | - INR | 18.09% |
| 2005 FY | - INR | 25.33% |
| 2004 FY | - INR | 0.0% |